Scout — literature reconnaissance
Type any drug or a clinical trial and Scout queries live PubMed and the openFDA FAERS pharmacovigilance database: a theoretical renal signature, a real-time acute-kidney-injury reporting signal, and every article the draft rests on. Each result also opens an on-demand cross-organ verdict grading plausible injury to other organ systems.
Educational tool — enter drug, organ, or trial identifiers only. Do not enter patient names or any other identifiable health information (PHI).
Experimental — hypothesis-generating only. Scout gathers automated PubMed evidence and live FAERS report counts, presenting a theoretical renal signature and reporting-odds-ratio only when the synthesis and report floors are met. Absent direct kidney evidence, it may show the renal patterns of mechanism-matched atlas drugs as a differential — never a finding for the searched agent. It is not medical advice, not a validated catalog entry, and may be wrong. Verify every claim against primary literature.
How it works
Three request-time lookups from a free-text query to a cited, degradation-tolerant draft.
Auto-research the literature
The drug name is translated into a structured PubMed nephrotoxicity query. Scout pulls the result count and the most relevant articles, then drafts a theoretical injury signature grounded in those titles — never inventing a citation.
Live FAERS signal
In parallel, Scout computes an acute-kidney-injury reporting-odds-ratio against the openFDA FAERS API — the same 2×2 recipe as our committed data — and flags a signal only when the 95% CI lower bound clears 1.
Trial fan-out
Give Scout an NCT id or a trial title and it resolves the study's drug interventions on ClinicalTrials.gov, then scouts each arm as its own card. Every upstream degrades gracefully — a sparse or unreachable source simply drops out.
- · The drafted signature is a hypothesis from titles and basic pharmacology — not a reviewed catalog entry. Absence of a PubMed signal for a new agent often reflects how new it is, not its safety.
- · FAERS is a spontaneous reporting system: the ROR measures reporting disproportionality, confounded by indication and notoriety, not incidence or proven causation.
- · Trial resolution only covers registered interventional studies, and a multi-arm study is capped so it can’t spawn unbounded lookups.
- · It generates leads to investigate — it does not establish causation or guide individual patient care.
Scout is an experimental, hypothesis-generating aid built on automated PubMed review and live FAERS pharmacovigilance signals; its output can be incomplete or wrong. It is not a diagnostic device or a substitute for clinical judgment, and must not guide decisions about real patients. Verify against primary literature and qualified clinicians.